Isolation and study of an acquired inhibitor of human coagulation factor V.
Open accessThe DOI matches its Crossref record.
Abstract
A coagulation Factor V inhibitor developed in a man 75 yr of age in association with an anaplastic malignancy and drug treatment (including the aminoglycoside antibiotic, gentamicin). The patient did not bleed abnormally, despite both surgical challenge and plasma Factor V activity of less than 1%. The inhibited plasma had grossly prolonged prothrombin and activated partial thromboplastin times, but a normal thrombin time. Mixing studies indicated progressive coagulation inhibition with normal plasma, but not with Factor V-deficient plasma, and reversal of coagulation inhibition by the addition of bovine Factor V to the patient's plasma. 1 ml of patient plasma inhibited the Factor V activity of 90 ml of normal human plasma. The inhibitor was isolated by sequential affinity chromatography on protein A-Sepharose and Factor V-Sepharose. The IgG isolate markedly inhibits the activity of prothrombinase assembled from purified Factors Xa and Va, calcium ion, and phospholipid vesicles, and partially inhibits prothrombinase assembled from purified Factor Xa, calcium ion, and normal platelets. The Factor V of platelets, however, appears relatively inaccessible to the antibody, inasmuch as platelets isolated from whole blood supplemented for 8 h with the antibody functioned normally with respect to platelet Factor V-mediated prothrombinase function. The absence of obvious hemorrhagic difficulties in the patient, the total inhibition of plasma Factor V by the inhibitor, and the apparent inaccessibility of platelet Factor V to the inhibitor specifically implicate platelet Factor V in the maintenance of hemostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bolton‐Maggs, P. H. B., Perry, D. J., Chalmers, E. A., Parapia, L. A., Wilde, J. T., Williams, M. D., Collins, P. W., Kitchen, S., Dolan, G., & Mumford, A. D. (2004) · Haemophilia · doi:10.1111/j.1365-2516.2004.00944.x · Cited by 546
The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis, M., Rand, M. D., & Mann, K. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31776-9 · Cited by 405
Self-citationAlberio, L., Safa, O., Clemetson, K. J., Esmon, C. T., & Dale, G. L. (2000) · Blood · doi:10.1182/blood.v95.5.1694.005k24_1694_1702 · Cited by 278
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO
W Collins, P., Chalmers, E., Hart, D., Jennings, I., Liesner, R., Rangarajan, S., Talks, K., Williams, M., & R. M. Hay, C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12463 · Cited by 159
“The bleeding phenotype may be related to the susceptibility of FV in the platelet alpha granule to be neutralized (Chediak et al, 1980; Nesheim et al, 1986).”
Background
Metadata
- Authors
- Nesheim, M. E., Nichols, W. L., Cole, T. L., Houston, J. G., Schenk, R. B., Mann, K. G., & Bowie, E. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1986-02-01
- Volume
- 77
- Issue
- 2
- Pages
- 405-415
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2008588731
- Cited by
- 159
- References
- 0
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isolation and study of an acquired inhibitor of human coagulation factor V. https://app.cochat.ai/papers/10.1172/jci112318
- The paper
- Nesheim, M. E., Nichols, W. L., Cole, T. L., Houston, J. G., Schenk, R. B., Mann, K. G., & Bowie, E. J. (1986). Isolation and study of an acquired inhibitor of human coagulation factor V. Journal of Clinical Investigation. https://doi.org/10.1172/jci112318
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.